March 16, 2017
AstraZeneca AB and Zydus Pharmaceuticals USA Inc., an American subsidiary of Indian drugmaker Zydus Cadila, have settled a New Jersey federal lawsuit alleging that Zydus' plans to manufacture generic versions of Nexium infringe AstraZeneca's patents on the heartburn drug.
August 01, 2014
AstraZeneca AB hit Zydus Pharmaceuticals USA Inc., an American subsidiary of Indian drugmaker Zydus Cadila, with a lawsuit Thursday in New Jersey federal court claiming Zydus' plans to manufacture generic Nexium infringes on AstraZeneca's patents on the popular heartburn drug.